LENSAR, Inc. (NASDAQ:LNSR) Director Acquires $57,376.27 in Stock

LENSAR, Inc. (NASDAQ:LNSR – Get Rating) Director Aimee S. Weisner bought 22,153 shares of the business’s stock in a transaction on Friday, May 19th. The shares were acquired at an average price of $2.59 per share, for a total transaction of $57,376.27. Following the completion of the transaction, the director now owns 37,638 shares in the company, valued at approximately $97,482.42. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

LENSAR Stock Down 4.9 %

Shares of LNSR stock opened at $2.51 on Monday. The stock has a 50-day moving average of $2.60 and a 200-day moving average of $2.97. LENSAR, Inc. has a one year low of $1.90 and a one year high of $7.59.

LENSAR (NASDAQ:LNSR – Get Rating) last posted its earnings results on Monday, May 15th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.13). LENSAR had a negative return on equity of 41.47% and a negative net margin of 51.10%. The business had revenue of $8.25 million for the quarter.

Hedge Funds Weigh In On LENSAR

Several hedge funds have recently made changes to their positions in LNSR. North Run Capital LP boosted its holdings in shares of LENSAR by 17.3% in the 4th quarter. North Run Capital LP now owns 1,096,406 shares of the company’s stock valued at $3,245,000 after buying an additional 161,896 shares during the last quarter. Vanguard Group Inc. lifted its holdings in LENSAR by 6.4% during the 1st quarter. Vanguard Group Inc. now owns 433,293 shares of the company’s stock valued at $3,207,000 after purchasing an additional 26,117 shares during the last quarter. DCF Advisers LLC lifted its holdings in LENSAR by 2.6% during the 1st quarter. DCF Advisers LLC now owns 287,023 shares of the company’s stock valued at $2,124,000 after purchasing an additional 7,235 shares during the last quarter. State Street Corp lifted its holdings in LENSAR by 5.1% during the 1st quarter. State Street Corp now owns 34,791 shares of the company’s stock valued at $257,000 after purchasing an additional 1,697 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. acquired a new stake in LENSAR during the 1st quarter valued at $86,000. 54.43% of the stock is owned by institutional investors.

LENSAR Company Profile

(Get Rating)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.